|
1
|
Orr WS, Denbo JW, Billups CA, Wu J, Navid
F, Rao BN, Davidoff AM and Krasin MJ: Analysis of prognostic
factors in extraosseous Ewing sarcoma family of tumors: Review of
St. Jude Children's Research Hospital experience. Ann Surg Oncol.
19:3816–3822. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fleuren ED, Versleijen-Jonkers YM, Boerman
OC and van der Graaf WT: Targeting receptor tyrosine kinases in
osteosarcoma and Ewing sarcoma: Current hurdles and future
perspectives. Biochim Biophys Acta. 1845:266–276. 2014.PubMed/NCBI
|
|
3
|
Zhang Z, Huang L, Yu Z, Chen X, Yang D,
Zhan P, Dai M, Huang S, Han Z and Cao K: Let-7a functions as a
tumor suppressor in Ewing's sarcoma cell lines partly by targeting
cyclin-dependent kinase 6. DNA Cell Biol. 33:136–147. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gaspar N, Hawkins DS, Dirksen U, Lewis IJ,
Ferrari S, Le Deley MC, Kovar H, Grimer R, Whelan J, Claude L, et
al: Ewing sarcoma: Current management and future approaches through
collaboration. J Clin Oncol. 33:3036–3046. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Shao G, Zhang M, Zhu F, Zhao B, He C
and Zhang Z: miR-124 represses the mesenchymal features and
suppresses metastasis in Ewing sarcoma. Oncotarget. 8:10274–10286.
2017.PubMed/NCBI
|
|
6
|
Felgenhauer JL, Nieder ML, Krailo MD,
Bernstein ML, Henry DW, Malkin D, Baruchel S, Chuba PJ, Sailer SL,
Brown K, et al: A pilot study of low-dose anti-angiogenic
chemotherapy in combination with standard multiagent chemotherapy
for patients with newly diagnosed metastatic Ewing sarcoma family
of tumors: A children's oncology group (COG) phase II study
NCT00061893. Pediatr Blood Cancer. 60:409–414. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haga A, Ogawara Y, Kubota D, Kitabayashi
I, Murakami Y and Kondo T: Interactomic approach for evaluating
nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
Electrophoresis. 34:1670–1678. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scotlandi K, Avnet S, Benini S, Manara MC,
Serra M, Cerisano V, Perdichizzi S, Lollini PL, De Giovanni C,
Landuzzi L and Picci P: Expression of an IGF-I receptor dominant
negative mutant induces apoptosis, inhibits tumorigenesis and
enhances chemosensitivity in Ewing's sarcoma cells. Int J Cancer.
101:11–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herrero-Martín D, Osuna D, Ordóñez JL,
Sevillano V, Martins AS, Mackintosh C, Campos M, Madoz-Gúrpide J,
Otero-Motta AP, Caballero G, et al: Stable interference of EWS-FLI1
in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and
reveals TOPK as a new target. Br J Cancer. 101:80–90. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Landuzzi L, De Giovanni C, Nicoletti G,
Rossi I, Ricci C, Astolfi A, Scopece L, Scotlandi K, Serra M,
Bagnara GP, et al: The metastatic ability of Ewing's sarcoma cells
is modulated by stem cell factor and by its receptor c-kit. Am J
Pathol. 157:2123–2131. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brohl AS, Solomon DA, Chang W, Wang J,
Song Y, Sindiri S, Patidar R, Hurd L, Chen L, Shern JF, et al: The
genomic landscape of the Ewing sarcoma family of tumors reveals
recurrent STAG2 mutation. PLoS Genet. 10:e10044752014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang YX, Mandal D, Wang S, Hughes D,
Pollock RE, Lev D, Kleinerman E and Hayes-Jordan A: Inhibiting
platelet-derived growth factor beta reduces Ewing's sarcoma growth
and metastasis in a novel orthotopic human xenograft model. In
Vivo. 23:903–909. 2009.PubMed/NCBI
|
|
13
|
Do I, Araujo ES, Kalil RK, Bacchini P,
Bertoni F, Unni KK and Park YK: Protein expression of KIT and gene
mutation of c-kit and PDGFRs in Ewing sarcomas. Pathol Res Pract.
203:127–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahmed AA, Sherman AK and Pawel BR:
Expression of therapeutic targets in Ewing sarcoma family tumors.
Hum Pathol. 43:1077–1083. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Crompton BD, Stewart C, Taylor-Weiner A,
Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA,
Mehta SS, et al: The genomic landscape of pediatric Ewing sarcoma.
Cancer Discov. 4:1326–1341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lerman DM, Monument MJ, McIlvaine E, Liu
XQ, Huang D, Monovich L, Beeler N, Gorlick RG, Marina NM, Womer RB,
et al: Tumoral TP53 and/or CDKN2A alterations are not reliable
prognostic biomarkers in patients with localized Ewing sarcoma: A
report from the children's oncology group. Pediatr Blood Cancer.
62:759–765. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41((Database Issue)):
D991–D995. 2013.PubMed/NCBI
|
|
18
|
Savola S, Klami A, Myllykangas S, Manara
C, Scotlandi K, Picci P, Knuutila S and Vakkila J: High expression
of complement component 5 (C5) at tumor site associates with
superior survival in Ewing's sarcoma family of tumour patients.
ISRN Oncol. 2011:1687122011.PubMed/NCBI
|
|
19
|
Agelopoulos K, Richter GH, Schmidt E,
Dirksen U, von Heyking K, Moser B, Klein HU, Kontny U, Dugas M,
Poos K, et al: Deep sequencing in conjunction with expression and
functional analyses reveals activation of FGFR1 in Ewing sarcoma.
Clin Cancer Res. 21:4935–4946. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leek JT, Johnson WE, Parker HS, Jaffe AE
and Storey JD: The sva package for removing batch effects and other
unwanted variation in high-throughput experiments. Bioinformatics.
28:882–883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Doncheva NT, Assenov Y, Domingues FS and
Albrecht M: Topological analysis and interactive visualization of
biological networks and protein structures. Nat Protoc Nature
protocols. 7:670–685. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: cytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Durisová M and Dedik L: SURVIVAL-an
integrated software package for survival curve estimation and
statistical comparison of survival rates of two groups of patients
or experimental animals. Methods Find Exp Clin Pharmacol.
15:535–540. 1993.PubMed/NCBI
|
|
29
|
Unal I: Defining an optimal cut-point
value in ROC analysis: An alternative approach. Comput Math Methods
Med. 2017:37626512017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Van Mater D and Wagner L: Management of
recurrent Ewing sarcoma: Challenges and approaches. Onco Targets
Ther. 12:2279–2288. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sandberg AA and Bridge JA: Updates on
cytogenetics and molecular genetics of bone and soft tissue tumors:
Ewing sarcoma and peripheral primitive neuroectodermal tumors.
Cancer Genet Cytogenet. 123:1–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chaber R, Łach K, Arthur CJ, Raciborska A,
Michalak E, Ciebiera K, Bilska K, Drabko K and Cebulski J:
Prediction of Ewing Sarcoma treatment outcome using attenuated
tissue reflection FTIR tissue spectroscopy. Sci Rep. 8:122992018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Esiashvili N, Goodman M and Marcus RB Jr:
Changes in incidence and survival of Ewing sarcoma patients over
the past 3 decades: Surveillance epidemiology and end results data.
J Pediatr Hematol Oncol. 30:425–430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bosma SE, Ayu O, Fiocco M, Gelderblom H
and Dijkstra PDS: Prognostic factors for survival in Ewing sarcoma:
A systematic review. Surg Oncol. 27:603–610. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Koppenhafer SL, Goss KL, Terry WW and
Gordon DJ: mTORC1/2 and protein translation regulate levels of CHK1
and the sensitivity to CHK1 inhibitors in Ewing sarcoma cells. Mol
Cancer Ther. 17:2676–2688. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin L, Huang M, Shi X, Mayakonda A, Hu K,
Jiang YY, Guo X, Chen L, Pang B, Doan N, et al:
Super-enhancer-associated MEIS1 promotes transcriptional
dysregulation in Ewing sarcoma in co-operation with EWS-FLI1.
Nucleic Acids Res. 47:1255–1267. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Henrich IC, Young R, Quick L, Oliveira AM
and Chou MM: USP6 confers sensitivity to IFN-mediated apoptosis
through modulation of TRAIL signaling in Ewing sarcoma. Mol Cancer
Res. 16:1834–1843. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xia L, Su X, Shen J, Meng Q, Yan J, Zhang
C, Chen Y, Wang H and Xu M: ANLN functions as a key candidate gene
in cervical cancer as determined by integrated bioinformatic
analysis. Cancer Manag Res. 10:663–670. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xia P and Xu XY: Prognostic significance
of CD44 in human colon cancer and gastric cancer: Evidence from
bioinformatic analyses. Oncotarget. 7:45538–45546. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mendoza-Naranjo A, El-Naggar A, Wai DH,
Mistry P, Lazic N, Ayala FR, da Cunha IW, Rodriguez-Viciana P,
Cheng H, Tavares Guerreiro Fregnani JH, et al: ERBB4 confers
metastatic capacity in Ewing sarcoma. EMBO Mol Med. 5:1087–1102.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Qin H and Liu W: MicroRNA-99a-5p
suppresses breast cancer progression and cell-cycle pathway through
downregulating CDC25A. J Cell Physiol. 234:3526–3537. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang J, Jia N, Lyv T, Wang C, Tao X, Wong
K, Li Q and Feng W: Paired box 2 promotes progression of
endometrial cancer via regulating cell cycle pathway. J Cancer.
9:3743–3754. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhao F, Zhou LH, Ge YZ, Ping WW, Wu X, Xu
ZL, Wang M, Sha ZL and Jia RP: MicroRNA-133b suppresses bladder
cancer malignancy by targeting TAGLN2-mediated cell cycle. J Cell
Physiol. 234:4910–4923. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang L, Kang W, Lu X, Ma S, Dong L and
Zou B: LncRNA CASC11 promoted gastric cancer cell proliferation,
migration and invasion in vitro by regulating cell cycle pathway.
Cell Cycle. 17:1886–1900. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Guenther LM, Dharia NV, Ross L, Conway A,
Robichaud AL, Catlett JL II, Wechsler CS, Frank ES, Goodale A,
Church AJ, et al: A combination CDK4/6 and IGF1R inhibitor strategy
for Ewing sarcoma. Clin Cancer Res. 25:1343–1357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lorin S, Borges A, Ribeiro Dos Santos L,
Souquère S, Pierron G, Ryan KM, Codogno P and Djavaheri-Mergny M:
c-Jun NH2-terminal kinase activation is essential for
DRAM-dependent induction of autophagy and apoptosis in
2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res.
69:6924–6931. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wilky BA, Kim C, McCarty G, Montgomery EA,
Kammers K, DeVine LR, Cole RN, Raman V and Loeb DM: RNA helicase
DDX3: A novel therapeutic target in Ewing sarcoma. Oncogene.
35:2574–2583. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tong DL, Boocock DJ, Dhondalay GK, Lemetre
C and Ball GR: Artificial neural network inference (ANNI): A study
on gene-gene interaction for biomarkers in childhood sarcomas. PLoS
One. 9:e1024832014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cheung IY, Feng Y, Danis K, Shukla N,
Meyers P, Ladanyi M and Cheung NK: Novel markers of subclinical
disease for Ewing family tumors from gene expression profiling.
Clin Cancer Res. 13:6978–6983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ohali A, Avigad S, Zaizov R, Ophir R,
Horn-Saban S, Cohen IJ, Meller I, Kollender Y, Issakov J and Yaniv
I: Prediction of high risk Ewing's sarcoma by gene expression
profiling. Oncogene. 23:8997–9006. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kikuta K, Tochigi N, Shimoda T, Yabe H,
Morioka H, Toyama Y, Hosono A, Beppu Y, Kawai A, Hirohashi S and
Kondo T: Nucleophosmin as a candidate prognostic biomarker of
Ewing's sarcoma revealed by proteomics. Clin Cancer Res.
15:2885–2894. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wei B and Jin JP: TNNT1, TNNT2, and TNNT3:
Isoform genes, regulation, and structure-function relationships.
Gene. 582:1–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gupton SL, Anderson KL, Kole TP, Fischer
RS, Ponti A, Hitchcock-DeGregori SE, Danuser G, Fowler VM, Wirtz D,
Hanein D and Waterman-Storer CM: Cell migration without a
lamellipodium: Translation of actin dynamics into cell movement
mediated by tropomyosin. J Cell Biol. 168:619–631. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lees JG, Bach CT and O'Neill GM: Interior
decoration: Tropomyosin in actin dynamics and cell migration. Cell
Adh Migr. 5:181–186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nguyen TH and Barr FG: Therapeutic
approaches targeting PAX3-FOXO1 and its regulatory and
transcriptional pathways in rhabdomyosarcoma. Molecules. 23(pii):
E27982018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kawabe S, Mizutani T, Ishikane S, Martinez
ME, Kiyono Y, Miura K, Hosoda H, Imamichi Y, Kangawa K, Miyamoto K
and Yoshida Y: Establishment and characterization of a novel
orthotopic mouse model for human uterine sarcoma with different
metastatic potentials. Cancer Lett. 366:182–190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Davidson B, Abeler VM, Forsund M, Holth A,
Yang Y, Kobayashi Y, Chen L, Kristensen GB, Shih IeM and Wang TL:
Gene expression signatures of primary and metastatic uterine
leiomyosarcoma. Hum Pathol. 45:691–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Shi Y, Zhao Y, Zhang Y, AiErken N, Shao N,
Ye R, Lin Y and Wang S: TNNT1 facilitates proliferation of breast
cancer cells by promoting G1/S phase transition. Life
Sci. 208:161–166. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lawrenson K, Pakzamir E, Liu B, Lee JM,
Delgado MK, Duncan K, Gayther SA, Liu S, Roman L and
Mhawech-Fauceglia P: Molecular analysis of mixed endometrioid and
serous adenocarcinoma of the endometrium. PLoS One.
10:e01309092015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kuroda T, Yasuda S, Nakashima H, Takada N,
Matsuyama S, Kusakawa S, Umezawa A, Matsuyama A, Kawamata S and
Sato Y: Identification of a gene encoding slow skeletal muscle
troponin t as a novel marker for immortalization of retinal pigment
epithelial cells. Sci Rep. 7:81632017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Gu X, Li B, Jiang M, Fang M, Ji J, Wang A,
Wang M, Jiang X and Gao C: RNA sequencing reveals differentially
expressed genes as potential diagnostic and prognostic indicators
of gallbladder carcinoma. Oncotarget. 6:20661–20671. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Watanabe H, Atsuta N, Hirakawa A, Nakamura
R, Nakatochi M, Ishigaki S, Iida A, Ikegawa S, Kubo M, Yokoi D, et
al: A rapid functional decline type of amyotrophic lateral
sclerosis is linked to low expression of TTN. J Neurol Neurosurg
Psychiatry. 87:851–858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Herman DS, Lam L, Taylor MR, Wang L,
Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B,
Sparks E, et al: Truncations of titin causing dilated
cardiomyopathy. N Engl J Med. 366:619–628. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kim N, Hong Y, Kwon D and Yoon S: Somatic
mutaome profile in human cancer tissues. Genomics Inform.
11:239–244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wolff RK, Hoffman MD, Wolff EC, Herrick
JS, Sakoda LC, Samowitz WS and Slattery ML: Mutation analysis of
adenomas and carcinomas of the colon: Early and late drivers. Genes
Chromosomes Cancer. 57:366–376. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Bizama C, Benavente F, Salvatierra E,
Gutiérrez-Moraga A, Espinoza JA, Fernández EA, Roa I, Mazzolini G,
Sagredo EA, Gidekel M and Podhajcer OL: The low-abundance
transcriptome reveals novel biomarkers, specific intracellular
pathways and targetable genes associated with advanced gastric
cancer. Int J Cancer. 134:755–764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Yang CK, Yu TD, Han CY, Qin W, Liao XW, Yu
L, Liu XG, Zhu GZ, Su H, Lu SC, et al: Genome-wide association
study of MKI67 expression and its clinical implications in
HBV-related hepatocellular carcinoma in Southern China. Cell
Physiol Biochem. 42:1342–1357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Cheng X, Yin H, Fu J, Chen C, An J, Guan
J, Duan R, Li H and Shen H: Aggregate analysis based on TCGA: TTN
missense mutation correlates with favorable prognosis in lung
squamous cell carcinoma. J Cancer Res Clin Oncol. 145:1027–1035.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Caleshu C, Sakhuja R, Nussbaum RL,
Schiller NB, Ursell PC, Eng C, De Marco T, McGlothlin D, Burchard
EG and Rame JE: Furthering the link between the sarcomere and
primary cardiomyopathies: Restrictive cardiomyopathy associated
with multiple mutations in genes previously associated with
hypertrophic or dilated cardiomyopathy. Am J Med Genet A 155A.
2229–2235. 2011. View Article : Google Scholar
|
|
70
|
Kalia SS, Adelman K, Bale SJ, Chung WK,
Eng C, Evans JP, Herman GE, Hufnagel SB, Klein TE, Korf BR, et al:
Recommendations for reporting of secondary findings in clinical
exome and genome sequencing, 2016 update (ACMG SF v2.0): A policy
statement of the American college of medical genetics and genomics.
Genet Med. 19:249–255. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Grabarek Z: Structural basis for diversity
of the EF-hand calcium-binding proteins. J Mol Biol. 359:509–525.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Morano I: Tuning smooth muscle contraction
by molecular motors. J Mol Med (Berl). 81:481–487. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Meder B, Laufer C, Hassel D, Just S,
Marquart S, Vogel B, Hess A, Fishman MC, Katus HA and Rottbauer W:
A single serine in the carboxyl terminus of cardiac essential
myosin light chain-1 controls cardiomyocyte contractility in vivo.
Circ Res. 104:650–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Gharahkhani P, Fitzgerald RC, Vaughan TL,
Palles C, Gockel I, Tomlinson I, Buas MF, May A, Gerges C, Anders
M, et al: Genome-wide association studies in oesophageal
adenocarcinoma and Barrett's oesophagus: A large-scale
meta-analysis. Lancet Oncol. 17:1363–1373. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Dalan AB, Gulluoglu S, Tuysuz EC, Kuskucu
A, Yaltirik CK, Ozturk O, Ture U and Bayrak OF: Simultaneous
analysis of miRNA-mRNA in human meningiomas by integrating
transcriptome: A relationship between PTX3 and miR-29c. BMC Cancer.
17:2072017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ito-Kureha T, Koshikawa N, Yamamoto M,
Semba K, Yamaguchi N, Yamamoto T, Seiki M and Inoue J: Tropomodulin
1 expression driven by NF-κB enhances breast cancer growth. Cancer
Res. 75:62–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Núñez-Enríquez JC, Bárcenas-López DA,
Hidalgo-Miranda A, Jiménez-Hernández E, Bekker-Méndez VC,
Flores-Lujano J, Solis-Labastida KA, Martínez-Morales GB,
Sánchez-Muñoz F, Espinoza-Hernández LE, et al: Gene expression
profiling of acute lymphoblastic leukemia in children with very
early relapse. Arch Med Res. 47:644–655. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Suzuki T, Kasamatsu A, Miyamoto I, Saito
T, Higo M, Endo-Sakamoto Y, Shiiba M, Tanzawa H and Uzawa K:
Overexpression of TMOD1 is associated with enhanced regional lymph
node metastasis in human oral cancer. Int J Oncol. 48:607–612.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Staaf J, Jönsson G, Ringnér M,
Vallon-Christersson J, Grabau D, Arason A, Gunnarsson H, Agnarsson
BA, Malmström PO, Johannsson OT, et al: High-resolution genomic and
expression analyses of copy number alterations in HER2-amplified
breast cancer. Breast Cancer Res. 12:R252010. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Pan X, Hu X, Zhang YH, Chen L, Zhu L, Wan
S, Huang T and Cai YD: Identification of the copy number variant
biomarkers for breast cancer subtypes. Mol Genet Genomics.
294:95–110. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Sawaki K, Kanda M, Miwa T, Umeda S, Tanaka
H, Tanaka C, Kobayashi D, Suenaga M, Hattori N, Hayashi M, et al:
Troponin I2 as a specific biomarker for prediction of peritoneal
metastasis in gastric cancer. Ann Surg Oncol. 25:2083–2090. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Postel-Vinay S, Véron AS, Tirode F,
Pierron G, Reynaud S, Kovar H, Oberlin O, Lapouble E, Ballet S,
Lucchesi C, et al: Common variants near TARDBP and EGR2 are
associated with susceptibility to Ewing sarcoma. Nat Genet.
44:323–327. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Schmiedel BJ, Hutter C, Hesse M and Staege
MS: Expression of multiple membrane-associated phospholipase A1
beta transcript variants and lysophosphatidic acid receptors in
Ewing tumor cells. Mol Biol Rep. 38:4619–4628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Foell JL, Hesse M, Volkmer I, Schmiedel
BJ, Neumann I and Staege MS: Membrane-associated phospholipase A1
beta (LIPI) Is an Ewing tumour-associated cancer/testis antigen.
Pediatr Blood Cancer. 51:228–234. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Kedage V, Selvaraj N, Nicholas TR, Budka
JA, Plotnik JP, Jerde TJ and Hollenhorst PC: An interaction with
Ewing's Sarcoma breakpoint protein EWS defines a specific oncogenic
mechanism of ETS factors rearranged in prostate cancer. Cell
Reports. 17:1289–1301. 2016. View Article : Google Scholar : PubMed/NCBI
|
